Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae.
Tigecycline is an expanded broad-spectrum antibacterial agent that is active against many clinically relevant species of bacterial pathogens, including Klebsiella pneumoniae. The majority of K. pneumoniae isolates are fully susceptible to tigecycline; however, a few strains that have decreased susceptibility have been isolated. One isolate, G340 (for which the tigecycline MIC is 4 microg/ml and which displays a multidrug resistance [MDR] phenotype), was selected for analysis of the mechanism for this decreased susceptibility by use of transposon mutagenesis with IS903phikan. A tigecycline-susceptible mutant of G340, GC7535, was obtained (tigecycline MIC, 0.25 microg/ml). Analysis of the transposon insertion mapped it to ramA, a gene that was previously identified to be involved in MDR in K. pneumoniae. For GC7535, the disruption of ramA led to a 16-fold decrease in the MIC of tigecycline and also a suppression of MDR. Trans-complementation with plasmid-borne ramA restored the original parental phenotype of decreased susceptibility to tigecycline. Northern blot analysis revealed a constitutive overexpression of ramA that correlated with an increased expression of the AcrAB transporter in G340 compared to that in tigecycline-susceptible strains. Laboratory mutants of K. pneumoniae with decreased susceptibility to tigecycline could be selected at a frequency of approximately 4 x 10(-8). These results suggest that ramA is associated with decreased tigecycline susceptibility in K. pneumoniae due to its role in the expression of the AcrAB multidrug efflux pump.
Ruzin
Alexey
A
Wyeth Research, Department of Infectious Disease, 401 North Middletown Rd., Bldg. 200, Rm. 3219, Pearl River, NY 10965, USA. ruzina@wyeth.com
Visalli
Melissa A
MA
Keeney
David
D
Bradford
Patricia A
PA
D001426:Bacterial Proteins / Q000502:physiology*; D004251:DNA Transposable Elements; D024901:Drug Resistance, Multiple, Bacterial; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000235:genetics; D026901:Membrane Transport Proteins / Q000235:genetics*; D008826:Microbial Sensitivity Tests; D008911:Minocycline / Q000031:analogs & derivatives* / Q000494:pharmacology*; D009154:Mutation; D000078304:Tigecycline
D001426:Bacterial Proteins; D004251:DNA Transposable Elements; D026901:Membrane Transport Proteins; C095947:RamA protein, Klebsiella; D000078304:Tigecycline; D008911:Minocycline
Microbiology. 1995 Aug;141 ( Pt 8):1909-20
7551053
Curr Med Chem. 2001 Dec;8(14):1699-711
11562289
Nucleic Acids Res. 1988 Aug 25;16(16):8186
3047679
Nature. 1970 Aug 15;227(5259):680-5
5432063
Antimicrob Agents Chemother. 2000 Aug;44(8):2225-9
10898710
Biotechniques. 1993 Nov;15(5):831-4
8267974
Antimicrob Agents Chemother. 2002 Feb;46(2):360-6
11796342
J Genet. 1949 Dec;49(3):264-85
24536673
J Bacteriol. 1999 Dec;181(23):7298-307
10572134
Antimicrob Agents Chemother. 2003 Sep;47(9):2831-7
12936981
J Bacteriol. 1990 Jul;172(7):4082-9
2193928
J Bacteriol. 1997 Oct;179(19):6122-6
9324261
J Bacteriol. 1996 Jan;178(1):306-8
8550435
Antimicrob Agents Chemother. 2003 Mar;47(3):972-8
12604529
Antimicrob Agents Chemother. 1999 Apr;43(4):738-44
10103174
Microbiol Immunol. 1997;41(9):697-702
9343820
Mol Microbiol. 1996 Aug;21(3):441-8
8866468
Clin Infect Dis. 1998 Aug;27 Suppl 1:S32-41
9710669
Microbiol Mol Biol Rev. 2002 Dec;66(4):671-701, table of contents
12456787
Antimicrob Agents Chemother. 2002 Aug;46(8):2595-601
12121938
Antimicrob Agents Chemother. 2003 Feb;47(2):665-9
12543675